We incorporate CY25 estimates and based on the above thesis, we expect the company to post Revenue/EBITDA/PAT growth of 18%/21%/25% CAGR over CY22-25E. We maintain our BUY rating on the stock with the revised TP of Rs 1,600/share (vs. TP of Rs 1,500/share) earlier.